Delivery Order SPE2DB24D1021-SPE2DB25FFAJD
- Not listed
- The Defense Logistics Agency awarded a $1,117.20 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes management medication. This competitively awarded, firm fixed-price contract was executed on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract carries no set-aside designation and represents a discrete order fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency (DLA) awarded a $14,019.04 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on September 26, 2025, with completion targeted for September 29, 2025. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,091.46 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes medication. The contract, issued on August 26, 2025, with completion targeted for August 27, 2025, carries firm fixed price terms and involves no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the performing location for this order. This delivery order represents a competitive award under...
- The Defense Logistics Agency awarded a delivery order valued at $1,273.37 to AmerisourceBergen Drug Corp for Januvia 100 mg tablets (90-count units) with an ultimate completion date of August 18, 2025. This competitive, non-set-aside delivery order utilizes firm fixed pricing and represents a single pharmaceutical supply transaction under AmerisourceBergen's existing contract vehicle with DLA. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $25,361.92 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, with an ultimate completion date of August 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is listed as...
- The Defense Logistics Agency awarded a $5,078.66 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,665.65 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract. The award, issued on June 27, 2025, with a completion date of June 30, 2025, represents a non-set-aside competitive procurement. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,118.08 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units). This competitively awarded, firm fixed-price delivery order was issued on April 23, 2025, with an ultimate completion date of April 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $19,581.28 to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, with an ultimate completion date of August 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $15,034.57 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 30, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFAJDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,516.76 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes medication. The contract was awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, and carries a firm fixed price structure with no set-aside designation. This delivery order represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive IDC with DLA enables it to supply a comprehensive range of pharmaceutical products, brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs globally. This delivery order for Januvia reflects the company's role in fulfilling ongoing pharmaceutical needs across the Defense Health Agency and other federal healthcare systems through the broader DLA Pharmaceutical Prime Vendor Global Program framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/5/25 |